Guidelines on number of embryos transferred

被引：100

作者：

Fritz, Marc A.

Ory, Steven J.

Barnhart, Kurt T. ^{[3
]}

Catherine, William H.

Cedars, Marcelle I.

Collins, John

Goldberg, Jeffrey M.

Gracia, Clarisa ^{[4
]}

Licht, Mark

Liu, James H. ^{[5
,6
,7
]}

Racowsky, Catherine

Schattman, Glenn

Thomas, Michael A. ^{[8
,9
]}

Rebar, Robert W.

La Barbera, Andrew R.

Battaglia, David

Pool, Thomas Rusty

Propst, Anthony

Reed, Michael

Sakkas, Denny

Sharara, Fady

Vernon, Michael

Widra, Eric

机构：

[1] Amer Soc Reprod Med, Birmingham, AL USA

[2] Soc Assisted Reprod Technol, Birmingham, AL USA

[3] Third Wave Technol Inc, Madison, WI USA

[4] Pfizer Inc, New York, NY USA

[5] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany

[6] Teva Pharmaceut USA, N Wales, PA USA

[7] Solvay Pharmaceut Inc, Marietta, GA USA

[8] Watson Pharmaceut Inc, Corola, PA USA

[9] Bayer HealthCare, Tarrytown, NY USA

来源：

FERTILITY AND STERILITY | 2009年 / 92卷 / 05期

关键词：

D O I：

10.1016/j.fertnstert.2009.08.059

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Based on American Society for Reproductive Medicine (ASRM) and Society for Assisted Reproductive Technology data available in 2007, ASRM's guidelines for the number of embryos to be transferred in in vitro fertilization cycles have been further refined in continuing efforts to reduce the number of higher-order multiple pregnancies. This version replaces the document of the same name that was published most recently in November 2008. (Fertil Steril (R) 2009;92:1518-9. (C) 2009 by American Society for Reproductive Medicine.)

引用

页码：1518 / 1519

页数：2

共 5 条

[1]

Pandian Z, 2009, COCHRANE DB SYST REV, V2

[2] HIGH-ORDER OOCYTE TRANSFER IN GAMETE INTRAFALLOPIAN TRANSFER PATIENTS 40 OR MORE YEARS OF AGE [J].